"A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 IN PATIENTS WITH EPISODIC CLUSTER HEADACHE."

Registry ID

I5Q-MC-CGAL(A)

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

ELI LILLY CANADA INC

Start date

2015-05-26

Last update

2015-05-08

Conditions

• EPISODIC CLUSTER HEADACHE

Related clinical trials

• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED, PARALLEL-GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF 2 DOSE REGIMENS (INTRAVENOUS/SUBCUTANEOUS AND SUBCUTANEOUS) OF TEV-48125 VERSUS PLACEBO FOR THE PREVENTION OF EPISODIC CLUSTER HEADACHE

View on source registry